TFF PHARMAC.INC.  DL-,001
TFF PHARMAC.INC. DL-,001
Action · US87241J2033 · TFFP · A3E2FW (XNCM)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - 7,69 % 3,16 % -77,61 % -96,45 % -99,95 %

Profil de l'entreprise pour TFF PHARMAC.INC. DL-,001 Action

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.

Données de l'entreprise

Nom TFF PHARMAC.INC. DL-,001
Société TFF Pharmaceuticals, Inc.
Symbole TFFP
Site web https://www.tffpharma.com
Marché d'origine XNCM Frankfurt
WKN A3E2FW
ISIN US87241J2033
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Harlan F. Weisman
Pays États-Unis d'Amérique
Devise EUR
Employés 0,0 T
Adresse 1751 River Run, 76107 Austin
Date d'introduction en bourse 2019-10-25

Symboles boursiers

Nom Symbole
NASDAQ TFFP

Autres actions

Les investisseurs qui détiennent TFF PHARMAC.INC. DL-,001 ont également les actions suivantes dans leur portefeuille :
BANK AMERI. 19/30 FLR MTN
BANK AMERI. 19/30 FLR MTN Obligation
CIA EN.GER. ADR 1
CIA EN.GER. ADR 1 Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025